Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 8 (2011), Issue 4 (April)

1. A Monte Carlo method to evaluate the impact of positioning errors on detector response and quality correction factors in nonstandard beams.
   Phys Med Biol, 56(8): 2617-34. [Abstract] [Full-text]
2. The effect of different control point sampling sequences on convergence of VMAT inverse planning.
   Phys Med Biol, 56(8): 2569-83. [Abstract] [Full-text]
3. Fixed number of segments in unidirectional decompositions of fluence matrices for step-and-shoot IMRT.
   Phys Med Biol, 56(8): 2601-15. [Abstract] [Full-text]
4. Dosimetric characterization of an image-guided stereotactic small animal irradiator.
   Phys Med Biol, 56(8): 2585-99. [Abstract] [Full-text]
5. Analytical expressions for water-to-air stopping-power ratios relevant for accurate dosimetry in particle therapy.
   Phys Med Biol, 56(8): 2515-33. [Abstract] [Full-text]
6. Temporal characterization and in vitro comparison of cell survival following the delivery of 3D-conformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT).
   Phys Med Biol, 56(8): 2445-57. [Abstract] [Full-text]
7. Sensitivity study of proton radiography and comparison with kV and MV x-ray imaging using GEANT4 Monte Carlo simulations.
   Phys Med Biol, 56(8): 2407-21. [Abstract] [Full-text]
8. A critical analysis of the long-term impact of brachytherapy for prostate cancer: a review of the recent literature.
   Curr Opin Urol, 21(3): 219-24. [Abstract] [Full-text]
9. Contemporary role of radiation therapy in the adjuvant or salvage setting following radical prostatectomy.
   Curr Opin Urol, 21(3): 206-10. [Abstract] [Full-text]
10. Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial).
    Contemp Clin Trials, 32(3): 453-60. [Abstract] [Full-text]
11. Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphoma.
    Eur J Nucl Med Mol Imaging, 38(5): 874-83. [Abstract] [Full-text]
12. Prophylactic cranial irradiation in lung cancer.
    Cancer Treat Rev, 37(4): 261-5. [Abstract] [Full-text]
13. Patients' perspectives on fecal incontinence after brachytherapy for localized prostate cancer.
    Dis Colon Rectum, 54(5): 615-21. [Abstract] [Full-text]
14. Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study.
    Crit Rev Oncol Hematol, 78(2): 138-49. [Abstract] [Full-text]
15. Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions.
    Int J Radiat Oncol Biol Phys, 80(1): 6-16. [Abstract] [Full-text]
16. Urethroplasty for radiotherapy induced bulbomembranous strictures: a multi-institutional experience.
    J Urol, 185(5): 1761-5. [Abstract] [Full-text]
17. Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer.
    Int J Radiat Oncol Biol Phys, 80(1): 161-8. [Abstract] [Full-text]
18. Daily online cone beam computed tomography to assess interfractional motion in patients with intact cervical cancer.
    Int J Radiat Oncol Biol Phys, 80(1): 273-80. [Abstract] [Full-text]
19. Inhibitory effect of radiotherapy combined with weekly recombinant human endostatin on the human pulmonary adenocarcinoma A549 xenografts in nude mice.
    Lung Cancer, 72(2): 165-71. [Abstract] [Full-text]
20. Inter- and intrafraction patient positioning uncertainties for intracranial radiotherapy: a study of four frameless, thermoplastic mask-based immobilization strategies using daily cone-beam CT.
    Int J Radiat Oncol Biol Phys, 80(1): 281-90. [Abstract] [Full-text]
21. Evaluation of radiation dose and image quality for the Varian cone beam computed tomography system.
    Int J Radiat Oncol Biol Phys, 80(1): 291-300. [Abstract] [Full-text]
22. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Int J Radiat Oncol Biol Phys, 80(1): 306-13. [Abstract] [Full-text]
23. Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT).
    Int J Radiat Oncol Biol Phys, 80(1): 301-5. [Abstract] [Full-text]
24. Effect of breathing motion on radiotherapy dose accumulation in the abdomen using deformable registration.
    Int J Radiat Oncol Biol Phys, 80(1): 265-72. [Abstract] [Full-text]
25. Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery.
    Int J Radiat Oncol Biol Phys, 80(1): 17-24. [Abstract] [Full-text]
26. Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate.
    Int J Radiat Oncol Biol Phys, 80(1): 76-84. [Abstract] [Full-text]
27. Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy.
    Int J Radiat Oncol Biol Phys, 80(1): 85-90. [Abstract] [Full-text]
28. Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.
    Int J Radiat Oncol Biol Phys, 80(1): 148-53. [Abstract] [Full-text]
29. Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement.
    Int J Radiat Oncol Biol Phys, 80(1): 193-8. [Abstract] [Full-text]
30. Fractionated conformal radiotherapy for management of optic nerve sheath meningiomas: long-term outcomes of tumor control and visual function at a single institution.
    Int J Radiat Oncol Biol Phys, 80(1): 185-92. [Abstract] [Full-text]
31. Radiotherapy-induced hyperthyroidism in a cystinotic kidney transplant patient with Hodgkin lymphoma.
    Pediatr Transplant, 15(3): e56-9. [Abstract] [Full-text]
32. Accelerated partial breast irradiation: initial experience with the Intrabeam System.
    Surg Oncol, 20(2): 73-9. [Abstract] [Full-text]
33. Positive visualization of implanted devices with susceptibility gradient mapping using the original resolution.
    Magn Reson Med, 65(5): 1483-90. [Abstract] [Full-text]
34. Thermoresponsive polymeric radionuclide delivery system--an injectable brachytherapy.
    Eur J Pharm Sci, 42(5): 484-8. [Abstract] [Full-text]
35. Cardiovascular disease associated with radiotherapy: activation of nuclear factor kappa-B.
    J Intern Med, 269(5): 469-77. [Abstract] [Full-text]
36. Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen.
    Biol Blood Marrow Transplant, 17(5): 693-702. [Abstract] [Full-text]
37. Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy.
    J Immunother, 34(4): 397-402. [Abstract] [Full-text]
38. Long-term results: adjuvant radiotherapy in en bloc resection of sacrococcygeal chordoma is advisable.
    Spine (Phila Pa 1976), 36(10): E656-61. [Abstract] [Full-text]
39. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study.
    Cancer, 117(9): 1874-83. [Abstract] [Full-text]
40. Can point doses predict volumetric dose to rectum and bladder: a CT-based planning study in high dose rate intracavitary brachytherapy of cervical carcinoma?
    Br J Radiol, 84(1001): 441-8. [Abstract] [Full-text]
41. Pulsed brachytherapy: a modelled consideration of repair parameter uncertainties and their influence on treatment duration extension and daytime-only "block-schemes".
    Br J Radiol, 84(1001): 449-56. [Abstract] [Full-text]
42. NADPH oxidase inhibition attenuates total body irradiation-induced haematopoietic genomic instability.
    Mutagenesis, 26(3): 431-5. [Abstract] [Full-text]
43. A dual-inhibition study on vascular smooth muscle cells with meclofenamic acid and β-irradiation for the prevention of restenosis.
    J Vasc Interv Radiol, 22(5): 623-9. [Abstract] [Full-text]
44. A geodesic deformable model for automatic segmentation of image sequences applied to radiation therapy.
    Int J Comput Assist Radiol Surg, 6(3): 341-50. [Abstract] [Full-text]
45. Malignancy in vestibular schwannoma after stereotactic radiotherapy: a case report and review of the literature.
    Laryngoscope, 121(5): 923-8. [Abstract] [Full-text]
46. Radiation-induced osteosarcomas of the calvarium and skull base.
    Cancer, 117(10): 2120-6. [Abstract] [Full-text]
47. Material efficiency studies for a Compton camera designed to measure characteristic prompt gamma rays emitted during proton beam radiotherapy.
    Phys Med Biol, 56(10): 3047-59. [Abstract] [Full-text]
48. The effect of uterine motion and uterine margins on target and normal tissue doses in intensity modulated radiation therapy of cervical cancer.
    Phys Med Biol, 56(10): 2887-901. [Abstract] [Full-text]
49. A highly effective bifunctional ligand for radioimmunotherapy applications.
    Chem Commun (Camb), 47(19): 5584-6. [Abstract] [Full-text]
50. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
    Ann Oncol, 22(5): 1154-63. [Abstract] [Full-text]
51. Predictors of psychosocial adjustment during the postradiation treatment transition.
    West J Nurs Res, 33(4): 540-59. [Abstract] [Full-text]
52. Combination of IG-IMRT and permanent source prostate brachytherapy in patients with organ-confined prostate cancer: GU and GI toxicity and effect on erectile function.
    Brachytherapy, 10(3): 195-200. [Abstract] [Full-text]
53. A linear source table to determine the treatment times for cylindrical applicators used in high-dose rate brachytherapy.
    Brachytherapy, 10(3): 249-52. [Abstract] [Full-text]
54. Optimal application of the Contura multilumen balloon breast brachytherapy catheter vacuum port to deliver accelerated partial breast irradiation.
    Brachytherapy, 10(3): 184-9. [Abstract] [Full-text]
55. High-dose rate interstitial brachytherapy using two weekly sessions of 10 Gy each for patients with locally advanced cervical carcinoma.
    Brachytherapy, 10(3): 242-8. [Abstract] [Full-text]
56. Measurement of dose perturbation around shielded ovoids in high-dose-rate brachytherapy.
    Brachytherapy, 10(3): 232-41. [Abstract] [Full-text]
57. Local control and visual acuity following treatment of medium-sized ocular melanoma using a contact eye plaque: a single surgeon experience.
    Brachytherapy, 10(3): 228-31. [Abstract] [Full-text]
58. Treatment of facial cutaneous carcinoma with high-dose rate contact brachytherapy with customized molds.
    Brachytherapy, 10(3): 221-7. [Abstract] [Full-text]
59. A simple method for dose fusion from multimodality treatment of prostate cancer: brachytherapy to external beam therapy.
    Brachytherapy, 10(3): 214-20. [Abstract] [Full-text]
60. Combined radiofrequency ablation and high-dose rate brachytherapy for early-stage non-small-cell lung cancer.
    Brachytherapy, 10(3): 253-9. [Abstract] [Full-text]
61. Precedence for prostate brachytherapy.
    Brachytherapy, 10(3): 201-7. [Abstract] [Full-text]
62. Accelerated partial breast irradiation using the strut-adjusted volume implant single-entry hybrid catheter in brachytherapy for breast cancer in the setting of breast augmentation.
    Brachytherapy, 10(3): 178-83. [Abstract] [Full-text]
63. Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: preliminary clinical results and evaluation of patient satisfaction.
    Brachytherapy, 10(3): 171-7. [Abstract] [Full-text]
64. Intra-articular chromic phosphate (³²P) in the treatment of diffuse pigmented villonodular synovitis.
    Brachytherapy, 10(3): 190-4. [Abstract] [Full-text]
65. Effects of ellipsoid prostate deformation on dose delivery during permanent interstitial brachytherapy.
    Brachytherapy, 10(3): 208-13. [Abstract] [Full-text]
66. Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases.
    Blood, 117(17): 4642-50. [Abstract] [Full-text]

© 2004-2012 Radiotherapy Research Today. All Rights Reserved.